CD40 ligand in pathogenesis of autoimmune ovarian disease of day 3-thymectomized mice: Implication for CD40 ligand antibody therapy

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 1667-1674

  Sharp, Colin ^a,c   Thompson, Claire ^a,d   Samy, Eileen T ^a   Noelle, Randolph ^b   Tung, Kenneth S K ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CD45 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INFLAMMATION; INTERFERON PRODUCTION; LYMPHOCYTE FUNCTION; MEMORY CELL; MOUSE; NEWBORN; NEWBORN PERIOD; NONHUMAN; OOCYTE; OVARY DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; REMISSION; T LYMPHOCYTE ACTIVATION; THYMECTOMY; TISSUE INJURY;

EID: 0037441997     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.1667     Document Type: Article

References (37)

1. Lanzavecchia, A., and F. Sallusto. 2000. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290:92.
2. Noelle, R. J. 1996. CD40 and its ligand in host defense. Immunity 4:415.
3. Carayanniotis, G., S. R. Masters, and R. J. Noelle. 1997. Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90:421.
4. Griggs, N. D., S. S. Agersborg, R. J. Noelle, J. A. Ledbetter, P. S. Linsley, and K. S. Tung. 1996. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J. Exp. Med. 183:801.
5. Howard, L. M., A. J. Miga, C. L. Vanderlugt, M. C. Dal Canto, J. D. Laman, R. J. Noelle. and S. D. Miller. 1999. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Invest. 103:281.
6. Peterson, K. E., and H. Bradley-Mullen. 1999. CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis. J. Autoimmun. 12:1.
7. Samoilova, E. B., J. L. Horton, H. Zhang, and Y. Chen. 1997. CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation. J. Mol. Med. 75:603.
8. Schaub, M., S. Issazadeh, T. H. Stadlbauer, R. Peach, M. H. Sayegh, and S. J. Khoury. 1999. Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 96:158.
9. Mohan, C., Y. Shi, J. D. Laman, and S. K. Datta. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1470.
10. Mason, D., and F. Powrie. 1998. Control of immune pathology by regulatory T cells. Curr. Opin. Immunol. 10:649.
11. + T cells. Microb. Infect. 3:919.
12. Sakaguchi, S., T. Takahashi, S. Yamazaki, Y. Kuniyasu, M. Itoh, N. Sakaguchi, and J. Shimizu. 2001. Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: implications for autoimmunity and tumor immunity. Microb. Infect. 3:911.
13. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193:1311.
14. Taylor, P. A., T. M. Friedman, R. Korngold, R. J. Noelle, and B. R. Blazar. 2002. Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40: CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood 99:4601.
15. Sakaguchi, S., T. Takahashi, and Y. Nishizuka. 1982. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med. 156:1577.
16. Taguchi, O., and Y. Nishizuka. 1980. Autoimmune oophoritis in thymectomized mice: T cell requirement in adoptive cell transfer. Clin. Exp. Immunol. 42:324.
17. Alard, P., C. Thompson, S. S. Agersborg, J. Thatte, Y. Setiady, E. Samy, and K. S. Tung. 2001. Endogenous oocyte antigens are required for rapid induction and progression of autoimmune ovarian disease following day-3 thymectomy. J. Immunol. 166:4363.
18. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168:5979.
19. Gleeson, P. A., B. H. Toh, and I. R. van Driel. 1996. Organ-specific autoimmunity induced by lymphopenia. Immunol. Rev. 149:97.
20. Theofilopoulos, A. N., W. Dummer, and D. H. Kono. 2001. T cell homeostasis and systemic autoimmunity. J. Clin. Invest. 108:335.
21. Suri-Payer, E., K. Wei, and K. S. K. Tung. 2002. The day 3 thymectomy model of organ-specific autoimmunity. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, New York.
22. Foy, T. M., J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157.
23. Smith, H., Y. Sakamoto, K. Kasai, and K. S. Tung. 1991. Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy. J. Immunol. 147:2928.
24. Foy, T. M., A. Aruffo, J. Bajorath, J. E. Buhlmann, and R. J. Noelle. 1996. Immune regulation by CD40 and its ligand GP39. Annu. Rev. Immunol. 14:591.
25. Goldrath, A. W., L. Y. Bogatzki, and M. J. Bevan. 2000. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 192:557.
26. Cho, B. K., V. P. Rao, Q. Ge, H. N. Eisen, and J. Chen. 2000. Homeostasisstimulated proliferation drives naive T cells to differentiate directly into memory T cells. J. Exp. Med. 192:549.
27. Murali-Krishna, K., and R. Ahmed. 2000. Cutting edge: naive T cells masquerading as memory cells. J. Immunol. 165:1733.
28. + T cells by blocking the CD40-CD154 interactions. J. Immunol. 164:6005.
29. Bonomo, A., P. J. Kehn, E. Payer, L. Rizzo, A. W. Cheever, and E. M. Shevach. 1995. Pathogenesis of post-thymectomy autoimmunity: role of syngeneic MLR-reactive T cells. J. Immunol. 154:6602.
30. Le Campion, A., C. Bourgeois, F. Lambolez, B. Martin, S. Leaument, N. Dautigny, C. Tanchot, C. Penit, and B. Lucas. 2002. Naive T cells proliferate strongly in neonatal mice in response to self-peptide/self-MHC complexes. Proc. Natl. Acad. Sci. USA 99:4538.
31. + lymphocytes convert to anergic or memory-like cells in T celldeprived recipients. Eur. J. Immunol. 31:2256.
32. Prlic, M., B. R. Blazar, A. Khoruts, T. Zell, and S. C. Jameson. 2001. Homeostatic expansion occurs independently of costimulatory signals. J. Immunol. 167: 5664.
33. Nierkens, S., P. van Helden, M. Bol, R. Bleumink, P. van Kooten, S. Ramdien-Murli, L. Boon, and R. Pieters. 2002. Selective requirement for CD40-CD154 in drug-induced type 1 versus type 2 responses to trinitrophenylovalbumin. J. Immunol. 168:3747.
34. Howard, L. M., and S. D. Miller. 2001. Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ. J. Immunol. 166:1547.
35. Lehmann, P. V., E. E. Sercarz, T. Forsthuber, C. M. Dayan, and G. Gammon. 1993. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 14:203.
36. McRae, B. L., C. L. Vanderlugt, M. C. Dal Canto, and S. D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75.
37. Balasa, B., T. Krahl, G. Patstone, J. Lee, R. Tisch, H. O. McDevitt, and N. Sarvetnick. 1997. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 159:4620.